LISA LEHR: Open Payments
NPI 1801342233 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 15 payments from 12 companies in 2025. Trend: 2023 $317 · 2024 $394 · 2025 $360
Food & beverage: $337Education: $23
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 2 | $55 |
| Astellas Pharma US Inc | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| ARRAY BIOPHARMA INC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Geron Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
Products named: QINLOCK, Vyloy, KEYTRUDA, XALKORI, ICLUSIG, RYTELO, MONJUVI, XPOVIO.
Industry payments across TX — which companies pay providers there.
